IL179441A - Method of measuring the activity of egln enzyme and of identifying an agent that modulates activity of said enzyme - Google Patents
Method of measuring the activity of egln enzyme and of identifying an agent that modulates activity of said enzymeInfo
- Publication number
- IL179441A IL179441A IL179441A IL17944106A IL179441A IL 179441 A IL179441 A IL 179441A IL 179441 A IL179441 A IL 179441A IL 17944106 A IL17944106 A IL 17944106A IL 179441 A IL179441 A IL 179441A
- Authority
- IL
- Israel
- Prior art keywords
- activity
- enzyme
- measuring
- identifying
- egln
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
The present invention provides methods for measuring EGLN activity. The invention also provides novel peptides for use in the methods, and use of the methods to identify agents which modulate EGLN activity.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57532404P | 2004-05-28 | 2004-05-28 | |
PCT/US2005/018577 WO2005118836A2 (en) | 2004-05-28 | 2005-05-26 | Hif prolyl hydroxylase activity assay |
Publications (2)
Publication Number | Publication Date |
---|---|
IL179441A0 IL179441A0 (en) | 2007-05-15 |
IL179441A true IL179441A (en) | 2010-12-30 |
Family
ID=34979114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL179441A IL179441A (en) | 2004-05-28 | 2006-11-21 | Method of measuring the activity of egln enzyme and of identifying an agent that modulates activity of said enzyme |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080113383A1 (en) |
EP (1) | EP1766047B1 (en) |
JP (1) | JP2008500834A (en) |
AT (1) | ATE443775T1 (en) |
AU (1) | AU2005250412B2 (en) |
CA (1) | CA2567619A1 (en) |
DE (1) | DE602005016800D1 (en) |
ES (1) | ES2332798T3 (en) |
HK (1) | HK1102197A1 (en) |
IL (1) | IL179441A (en) |
NZ (1) | NZ551632A (en) |
WO (1) | WO2005118836A2 (en) |
ZA (1) | ZA200610164B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0707302B8 (en) | 2006-01-27 | 2021-05-25 | Fibrogen Inc | cyanoisoquinoline compounds that act on tissue damage associated with ischemia, hypoxia and anemia, as well as pharmaceutical composition comprising them |
US7588924B2 (en) | 2006-03-07 | 2009-09-15 | Procter & Gamble Company | Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase |
RU2461557C2 (en) | 2006-04-04 | 2012-09-20 | Файброджен, Инк. | Pyrrolo- and thiazolopyridine compounds (versions) and based pharmaceutical composition |
DK3026044T3 (en) | 2006-06-26 | 2019-02-18 | Akebia Therapeutics Inc | PROLYL HYDROXYLASE INHIBITORS AND METHODS FOR USE |
KR20140095105A (en) | 2009-11-06 | 2014-07-31 | 에르피오 세러퓨틱스 인코포레이티드 | Compositions and methods for treating colitis |
WO2012106472A1 (en) | 2011-02-02 | 2012-08-09 | Fibrogen, Inc. | Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase |
GB201102659D0 (en) | 2011-02-15 | 2011-03-30 | Isis Innovation | Assay |
NO2686520T3 (en) | 2011-06-06 | 2018-03-17 | ||
CN103717214A (en) | 2011-06-06 | 2014-04-09 | 阿克比治疗有限公司 | Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer |
GB201113101D0 (en) | 2011-07-28 | 2011-09-14 | Isis Innovation | Assay |
NZ700760A (en) | 2012-03-09 | 2016-08-26 | Fibrogen Inc | 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors |
HRP20220182T1 (en) | 2012-07-16 | 2022-04-29 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
ES2631655T3 (en) | 2012-07-16 | 2017-09-01 | Fibrogen, Inc. | Procedure for manufacturing isoquinoline compounds |
NZ753904A (en) | 2013-06-13 | 2020-07-31 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
JP2018502882A (en) | 2015-01-23 | 2018-02-01 | アケビア セラピューティクス インコーポレイテッドAkebia Therapeutics Inc. | Solid form of 2- (5- (3-fluorophenyl) -3-hydroxypicolinamide) acetic acid, its composition and use |
SI3277270T1 (en) | 2015-04-01 | 2022-04-29 | Akebia Therapeutics, Inc. | Compositions and methods for treating anemia |
CN112088155A (en) | 2018-05-09 | 2020-12-15 | 阿克比治疗有限公司 | Process for the preparation of 2- [ [5- (3-chlorophenyl) -3-hydroxypyridine-2-carbonyl ] amino ] acetic acid |
CN114577945B (en) * | 2022-03-10 | 2023-06-02 | 中国科学院兰州化学物理研究所 | Micelle electric chromatography method for screening prolyl hydroxylase 2 inhibitor from traditional Chinese medicine extract |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4590157B2 (en) * | 2001-03-21 | 2010-12-01 | アイシス イノヴェイション リミテッド | Assays, methods and means |
WO2003053997A2 (en) * | 2001-12-06 | 2003-07-03 | Fibrogen, Inc. | Methods of increasing endogenous erythropoietin (epo) |
-
2005
- 2005-05-26 EP EP05755214A patent/EP1766047B1/en active Active
- 2005-05-26 DE DE602005016800T patent/DE602005016800D1/en active Active
- 2005-05-26 JP JP2007515346A patent/JP2008500834A/en not_active Ceased
- 2005-05-26 US US11/597,261 patent/US20080113383A1/en not_active Abandoned
- 2005-05-26 WO PCT/US2005/018577 patent/WO2005118836A2/en active Application Filing
- 2005-05-26 AT AT05755214T patent/ATE443775T1/en not_active IP Right Cessation
- 2005-05-26 CA CA002567619A patent/CA2567619A1/en not_active Abandoned
- 2005-05-26 ES ES05755214T patent/ES2332798T3/en active Active
- 2005-05-26 NZ NZ551632A patent/NZ551632A/en unknown
- 2005-05-26 ZA ZA200610164A patent/ZA200610164B/en unknown
- 2005-05-26 AU AU2005250412A patent/AU2005250412B2/en not_active Ceased
-
2006
- 2006-11-21 IL IL179441A patent/IL179441A/en not_active IP Right Cessation
-
2007
- 2007-09-20 HK HK07110215.1A patent/HK1102197A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ551632A (en) | 2009-09-25 |
AU2005250412A1 (en) | 2005-12-15 |
IL179441A0 (en) | 2007-05-15 |
AU2005250412B2 (en) | 2009-09-17 |
ZA200610164B (en) | 2008-02-27 |
ATE443775T1 (en) | 2009-10-15 |
WO2005118836A2 (en) | 2005-12-15 |
CA2567619A1 (en) | 2005-12-15 |
EP1766047A2 (en) | 2007-03-28 |
DE602005016800D1 (en) | 2009-11-05 |
JP2008500834A (en) | 2008-01-17 |
HK1102197A1 (en) | 2007-11-09 |
EP1766047B1 (en) | 2009-09-23 |
ES2332798T3 (en) | 2010-02-12 |
WO2005118836A3 (en) | 2006-04-06 |
US20080113383A1 (en) | 2008-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL179441A (en) | Method of measuring the activity of egln enzyme and of identifying an agent that modulates activity of said enzyme | |
TW200616578A (en) | Fluid handling devices | |
WO2005082341A3 (en) | NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF | |
WO2007028110A3 (en) | Methods for using and identifying modulators of delta-like 4 | |
PL2426220T3 (en) | Tagged microorganisms and methods of tagging | |
EP1700120A4 (en) | Marker for neuromyelitis optica | |
WO2004020458A3 (en) | Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents | |
MX2010001657A (en) | Regulators of mmp-9 and uses therof. | |
ATE456666T1 (en) | METHOD FOR EVALUATION OF RIBONUCLEOTIDE SEQUENCES | |
DE602005013403D1 (en) | METHOD FOR DETECTING STREPTOCOCCUS AGALACTIAE BY ALPHA-GLUCOSIDASE ACTIVITY | |
MX2007002277A (en) | Methods for making retinoids and uses thereof. | |
GB2388190B (en) | Methods for measuring enzyme activity | |
MX2008011971A (en) | Proximity recording device and method. | |
ATE410677T1 (en) | BIOEQUIVALENCE TEST FOR IRON-CONTAINING FORMULATIONS | |
MX2008002123A (en) | Methods and compositions for determining a level of biologically active serum paraoxonase. | |
HK1100762A1 (en) | Method of determining the sympathetic tone and system for measurement thereof | |
WO2003087054A3 (en) | Methods for identifying compounds that modulate enzymatic activity | |
IL173104A0 (en) | Siva and ubiquintination | |
WO2007140308A3 (en) | Methods of screening for trpm4 modulators of insulin secretion | |
MX2010004097A (en) | Complexes of trpc domains and sestd1 domains and methods and uses involving the same. | |
IL186259A0 (en) | Fragrance tester and method of applying a fragrance | |
WO2005093411A3 (en) | Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxigenase and methods of using the same | |
WO2007032717A8 (en) | A method for identifying an agent that modulates arginine transport in a chondrocyte | |
TW200743799A (en) | Methods and apparatus for enzyme inhibitors analysis | |
WO2005069859A3 (en) | Compositions and methods for modulating dhr96 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |